Evidence map›Paper›PMID 30761159›Full record

ArticleFrontiers in immunology2018

Acquired and Innate Immunity Impairment and Severe Disseminated

Luis Ignacio Gonzalez-Granado, Raquel Ruiz-García, Javier Blas-Espada, José Manuel Moreno-Villares, Marta Germán-Diaz, Marta López-Nevado, Estela Paz-Artal, Oscar Toldos, Yolanda Rodriguez-Gil, Jaime de Inocencio and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Open forum infectious diseases · 2022
    Review
  7. Article
  8. DetrimentalFrontiers in immunology · 2022
    Article
  9. A Pathogenic Missense Variant inFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Luis Ignacio Gonzalez-GranadoPrimary Immunodeficiencies Unit, Department of Pediatrics, School of Medicine, University Hospital 12 de Octubre, Complutense University of Madrid, Madrid, Spain.
Raquel Ruiz-GarcíaResearch Institute Hospital 12 Octubre (I+12), Madrid, Spain.
Javier Blas-EspadaResearch Institute Hospital 12 Octubre (I+12), Madrid, Spain.
José Manuel Moreno-VillaresPediatric Nutrition, Pediatrics, University Hospital 12 de Octubre, Complutense University of Madrid, Madrid, Spain.
Marta Germán-DiazPediatric Nutrition, Pediatrics, University Hospital 12 de Octubre, Complutense University of Madrid, Madrid, Spain.
Marta López-NevadoResearch Institute Hospital 12 Octubre (I+12), Madrid, Spain.
Estela Paz-ArtalResearch Institute Hospital 12 Octubre (I+12), Madrid, Spain.
Oscar ToldosPathology Department, University Hospital 12 de Octubre, Madrid, Spain.
Yolanda Rodriguez-GilPathology Department, University Hospital 12 de Octubre, Madrid, Spain.
Jaime de InocencioPediatric Rheumatology Unit, Department of Pediatrics, University Hospital 12 de Octubre, Complutense University of Madrid, Madrid, Spain.
Nerea Domínguez-PinillaResearch Institute Hospital 12 Octubre (I+12), Madrid, Spain.
Luis M AllendeResearch Institute Hospital 12 Octubre (I+12), Madrid, Spain.
Research Institute Hospital 12 de Octubre · ESUniversidad Complutense de Madrid · ESHospital Virgen de la Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptive ImmunityImmunity, InnateBiopsyBone MarrowChildCytokinesHumansImmunologic Deficiency SyndromesImmunophenotypingMaleMutationMycobacteriumMycobacterium InfectionsNF-kappa B p50 SubunitPedigreePhenotypeCytokinesNF-kappa B p50 Subunitcommon variable immunodeficiencyfactor of kappa light polypeptide gene enhancer in B-cells 1Langerhans cell histiocytosismendelian susceptibility to mycobacterial diseaseMycobacterium genavenseNFKB1 geneprimary immunodeficiencysubmucosal lymphocytic plexitis

Identifiers

PMID30761159
PMCPMC6362422
OpenAlexW2914014785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.